Abrilumab
Monoclonal antibody | |
---|---|
Type | ? |
Source | Human |
Target | integrin alpha-4 beta-7 |
Clinical data | |
ATC code | none |
Identifiers | |
CAS Number | 1342290-43-0 |
ChemSpider | none |
Chemical and physical data | |
Formula | C6362H9806N1686O2014S52 |
Molar mass | 143.8 kg/mol |
Abrilumab[1] is a monoclonal antibody designed for the treatment of inflammatory bowel disease, ulcerative colitis, and Crohn's disease.[2]
This drug was developed by MedImmune.
References
- ↑ World Health Organization (2014). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 111" (PDF). WHO Drug Information. 28 (2).
- ↑ Statement On A Nonproprietary Name Adopted By The USAN Council - Abrilumab, American Medical Association.
External links
- Having an illness or condition that affects your bowels- Worried about Bowel problems
This article is issued from Wikipedia - version of the 7/18/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.